Arrowhead Pharmaceuticals, Inc. (ARWR)
86.74
-0.37
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
86.74
0.00 (0.00%)
After-Hours: 19:52
Arrowhead Pharmaceuticals Total Assets (Quarterly) : 2.112B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.112B |
| March 31, 2026 | 2.268B |
| December 31, 2025 | 1.604B |
| September 30, 2025 | 1.450B |
| June 30, 2025 | 1.381B |
| March 31, 2025 | 1.573B |
| December 31, 2024 | 1.014B |
| September 30, 2024 | 1.140B |
| June 30, 2024 | 883.76M |
| March 31, 2024 | 955.15M |
| December 31, 2023 | 626.29M |
| September 30, 2023 | 765.55M |
| June 30, 2023 | 795.86M |
| March 31, 2023 | 891.31M |
| December 31, 2022 | 891.49M |
| September 30, 2022 | 691.94M |
| June 30, 2022 | 751.78M |
| March 31, 2022 | 703.58M |
| December 31, 2021 | 638.54M |
| September 30, 2021 | 710.15M |
| June 30, 2021 | 734.93M |
| March 31, 2021 | 756.80M |
| December 31, 2020 | 499.25M |
| September 30, 2020 | 522.50M |
| June 30, 2020 | 555.73M |
| Date | Value |
|---|---|
| March 31, 2020 | 561.08M |
| December 31, 2019 | 587.60M |
| September 30, 2019 | 349.85M |
| June 30, 2019 | 336.83M |
| March 31, 2019 | 333.94M |
| December 31, 2018 | 340.95M |
| September 30, 2018 | 111.61M |
| June 30, 2018 | 112.90M |
| March 31, 2018 | 127.00M |
| December 31, 2017 | 88.22M |
| September 30, 2017 | 104.02M |
| June 30, 2017 | 115.08M |
| March 31, 2017 | 126.87M |
| December 31, 2016 | 144.26M |
| September 30, 2016 | 128.18M |
| June 30, 2016 | 85.53M |
| March 31, 2016 | 94.61M |
| December 31, 2015 | 111.38M |
| September 30, 2015 | 132.27M |
| June 30, 2015 | 145.19M |
| March 31, 2015 | 162.38M |
| December 31, 2014 | 162.14M |
| September 30, 2014 | 182.82M |
| June 30, 2014 | 196.62M |
| March 31, 2014 | 202.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 3.189B |
| Intellia Therapeutics, Inc. | 857.16M |
| Denali Therapeutics, Inc. | 1.158B |
| Twist Bioscience Corp. | 672.44M |
| Revolution Medicines, Inc. | 4.323B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.646B |
| Shareholders Equity (Quarterly) | 465.53M |
| Debt to Equity Ratio | 2.956 |
| Current Ratio | 5.899 |
| Net Debt Paydown Yield | -1.11% |